EU Aduhelm Filing: Biogen Faces Second High-Stakes Meeting At EMA

 
• By Neena Brizmohun
  
Aduhelm is Biogen and Eisai's drug for Alzheimer’s disease • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography